Feature Articles on Nutrition and Obesity Management
Obesity represents the most prevalent metabolic disease in the world, posing a significant public health threat. Obesity shortens life expectancy by increasing the risk of developing comorbidities such as type 2 diabetes or cardiovascular disease. A better understanding of the ethiopathology of exce...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_112475 | ||
005 | 20230808 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230808s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-8103-3 | ||
020 | |a 9783036581026 | ||
020 | |a 9783036581033 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-8103-3 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PS |2 bicssc | |
072 | 7 | |a JFCV |2 bicssc | |
100 | 1 | |a Gómez-Ambrosi, Javier |4 edt | |
700 | 1 | |a Gómez-Ambrosi, Javier |4 oth | |
245 | 1 | 0 | |a Feature Articles on Nutrition and Obesity Management |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (224 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Obesity represents the most prevalent metabolic disease in the world, posing a significant public health threat. Obesity shortens life expectancy by increasing the risk of developing comorbidities such as type 2 diabetes or cardiovascular disease. A better understanding of the ethiopathology of excess adiposity represents the pillar on which to base the effective management of obesity. In this sense, this reprint expands our knowledge about the wide array of drivers that can facilitate or contribute to the development of obesity. Moreover, some of the latest progress made in lifestyle, pharmacological and surgical approaches in the treatment of obesity are summarised. Novel concepts regarding the different obesity phenotypes, the use of telemedicine for the treatment of overweight and obesity, or the use of personalised avatars in the management of obesity are also reviewed. This reprint will be of interest for specialists in Endocrinology and Nutrition, but also for any individual interested in health issues related to nutrition. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
650 | 7 | |a Food & society |2 bicssc | |
653 | |a obesity | ||
653 | |a diet | ||
653 | |a ultra-processed food | ||
653 | |a NOVA classification | ||
653 | |a diet quality | ||
653 | |a dietary pattern | ||
653 | |a non-communicable disease | ||
653 | |a lifestyle intervention | ||
653 | |a telemedicine | ||
653 | |a COVID-19 pandemic | ||
653 | |a obesogens | ||
653 | |a "exposome" | ||
653 | |a environment | ||
653 | |a epigenetics | ||
653 | |a microbiota | ||
653 | |a antibiotics | ||
653 | |a viral infection | ||
653 | |a sleep | ||
653 | |a endocrine disruptors | ||
653 | |a brown adipose tissue | ||
653 | |a thermogenesis | ||
653 | |a Endobarrier | ||
653 | |a food preferences | ||
653 | |a eating behaviour | ||
653 | |a taste function | ||
653 | |a semaglutide | ||
653 | |a STEP program | ||
653 | |a weight loss | ||
653 | |a weight management | ||
653 | |a clinical trial | ||
653 | |a GLP-1 | ||
653 | |a inherited | ||
653 | |a acquired | ||
653 | |a exercise | ||
653 | |a mitochondria | ||
653 | |a Mediterranean diet | ||
653 | |a metabolic syndrome | ||
653 | |a plant-based foods | ||
653 | |a polyphenols | ||
653 | |a polyunsaturated fatty acids | ||
653 | |a metabolism | ||
653 | |a deep learning | ||
653 | |a gated recurrent unit | ||
653 | |a wearables | ||
653 | |a forecasting | ||
653 | |a diet plans | ||
653 | |a digital nutrition | ||
653 | |a nutrition education | ||
653 | |a DFU | ||
653 | |a nutrition supplementation | ||
653 | |a body composition | ||
653 | |a phase angle | ||
653 | |a protein | ||
653 | |a macronutrients | ||
653 | |a micronutrients | ||
653 | |a chronic wounds | ||
653 | |a wound healing | ||
653 | |a diabetic foot ulcer | ||
653 | |a adipose tissue | ||
653 | |a advanced glycation end-products | ||
653 | |a cardiometabolic risk | ||
653 | |a cardiovascular risk factors | ||
653 | |a novel targets | ||
653 | |a skin autofluorescence | ||
653 | |a ketogenic diet | ||
653 | |a overweight | ||
653 | |a modified Wishnofsky equation | ||
653 | |a modelling | ||
653 | |a long short-term memory | ||
653 | |a transformer | ||
653 | |a digital twin | ||
653 | |a SARIMAX | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7590 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/112475 |7 0 |z DOAB: description of the publication |